Figure 6.
Clinical results of anti-IGF-1R therapy: response to therapy in phase II trials for Figitumumab, R1507, and Cixutumumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.